ArticleOncotarget2017

Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells.

Jianlong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.